Fig 2.

Psoriasis and atopic dermatitis. Factors clinicians consider when choosing a second line systemic therapy due to loss of efficacy from the first therapy in patients with atopic dermatitis or psoriasis (N = 265). Each therapy selection factor was graded on a 5-point Likert scale from most important (1) to least important (5) with compiled data shown as boxplots. The number of responses collected per attribute ranged from 262 to 265. The horizontal bar indicates the median value, box ends demarcate the first and third quartiles, whiskers show the range of observations within 1.5 times the interquartile range below the first quartile and above the third quartile, and circles represent outliers.